Internal Medicine, Hematology & Oncology · Indianapolis, IN
NPI
1902916109
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
8111 S Emerson Ave Ste 101
Indianapolis, IN, 46237
Phone (317) 859-5252
Groups this clinician bills Medicare through
Medicare paid, 2024
$311K
12,692 services
Medicare patients, 2024
538
Average age 74
Drug cost, 2024
$3.6M
1,601 prescriptions
Company payments, 2025
$515
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Meghana Raghavendra was code 99214 (office e&m - established), 260 times for 112 patients. In total Meghana Raghavendra billed 12,692 services in 76 codes, and Medicare paid $311K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-09-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 260 | 112 | $71.63 | $19K |
| 99213 Office E&M - Established | Office | 222 | 172 | $58.02 | $13K |
| 99214 Office E&M - Established | Office | 218 | 112 | $84.23 | $18K |
| 99213 Office E&M - Established | Facility | 215 | 159 | $48.51 | $10K |
| 99215 Office E&M - Established | Facility | 138 | 57 | $106.10 | $15K |
| 99215 Office E&M - Established | Office | 80 | 39 | $119.94 | $9,595 |
| 99232 Hospital E&M - Subsequent | Facility | 74 | 50 | $57.33 | $4,243 |
| 99222 Hospital E&M - Initial | Facility | 53 | 51 | $94.44 | $5,005 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 51 | 13 | $0.50 | $25.53 |
| 96413 Chemotherapy Administration | Office | 39 | 14 | $89.23 | $3,480 |
| 99212 Office E&M - Established | Office | 36 | 36 | $31.07 | $1,118 |
| 85025 Blood Count | Office | 32 | 13 | $7.61 | $244 |
| 99205 Office E&M - New | Office | 32 | 32 | $151.74 | $4,856 |
| 99442 Telephone Services | Office | 31 | 29 | $62.40 | $1,934 |
| 99205 Office E&M - New | Facility | 30 | 30 | $133.30 | $3,999 |
By year: 2022 $424K for 13,663 services; 2023 $391K for 16,164 services; 2024 $311K for 12,692 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 32 | 13 | $7.61 | $244 |
Medicare prescription drug claims, 2024
In 2024, the drug Meghana Raghavendra prescribed most often to Medicare patients was Anastrozole, with 162 prescriptions and refills. In total Meghana Raghavendra wrote 1,601 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 162 | 439 | 52 | $2,021 |
| Eliquis Apixaban | 117 | 173 | 33 | $99K |
| Prochlorperazine Maleate Generic | 94 | 94 | 68 | $1,078 |
| Dexamethasone Generic | 86 | 89 | 38 | $1,534 |
| Letrozole Generic | 58 | 140 | 23 | $1,117 |
| Ondansetron Odt Ondansetron | 57 | 61 | 35 | $744 |
| Hydroxyurea Generic | 49 | 92 | 11 | $807 |
| Gabapentin Generic | 48 | 64 | 15 | $520 |
| Acyclovir Generic | 47 | 65 | 12 | $832 |
| Levothyroxine Sodium Generic | 44 | 58 | Under 11 | $231 |
| Prednisone Generic | 41 | 41 | 21 | $156 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 36 | 40 | 12 | $93.27 |
| Klor-Con M20 Potassium Chloride | 32 | 48 | 12 | $401 |
| Warfarin Sodium Generic | 31 | 80 | Under 11 | $99.62 |
| Tamoxifen Citrate Generic | 30 | 71 | 14 | $702 |
Brand drugs: - claims; generic drugs: 1,217 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Meghana Raghavendra $515 ($515 in general payments such as food, travel and fees) from 19 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $68.49.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 1 | $68.49 |
| Celgene Corporation BMY | 3 | $62.71 |
| Merck Sharp & Dohme LLC MRK | 2 | $51.4 |
| GlaxoSmithKline, LLC. GSK | 3 | $49.66 |
| Menarini Silicon Biosystems, Inc. | 1 | $41.36 |
| Janssen Biotech, Inc. JNJ | 1 | $35.35 |
| Servier Pharmaceuticals LLC | 2 | $31.11 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $25.87 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $19.56 |
| Gilead Sciences, Inc. GILD | 1 | $19.5 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.